home / scout

Targets — browse / sort / filter (view)

One row per human protein target with names + key evidence. Click column headers to SORT; use the facets to FILTER (tier, activation pair, known aptamer, EV-Map). UniProt IDs link to the source. Default sort is evidence_priority — a DETERMINISTIC, reproducible score computed from harvested evidence (structure / disease / predicted-surface / EV-detection). Filter has_structure=1 for the core set: targets with a reported 3D structure (the requirement the Kd layer is built around).

Data license: CC BY 4.0 · Data source: apt-scout automated curation pipeline (E. Dohi, NCNP) — values harvested from public databases; raw source stored per target

id
UniProt accession (human). Links to uniprot.org.
gene_symbol
Gene symbol (e.g. ITGB3).
protein_name
Protein name (UniProt).
tier
Tier 1 = PDB-anchored; Tier 1.5 = AlphaFold-confident.
has_structure
1 if the target protein has a reported experimental 3D structure (PDB). This is the CORE requirement the aptamer-Kd layer is built around — filter to 1 for the structure-backed set.
evidence_priority
DETERMINISTIC, reproducible prioritisation (0-1) computed at build time from real harvested columns: 0.35*experimental-structure(PDB=1 / AlphaFold-only=0.3) + 0.30*Open-Targets-top-disease-score + 0.20*PREDICTED-surface-accessibility(A_surface=1) + 0.15*EV-detection(EV-Map). A transparent ranking AID, not a validation; the surface/EV terms are PREDICTIONS/DETECTIONS, not measured EV-surface exposure. Recomputable exactly from this DB.
has_activation_state_pdb_pair
1 if a curated ACTIVE/INACTIVE PDB pair exists (only 11 targets).
in_cev_map
Detected in the EV-Map plasma-EV dataset (Rai & Greening 2025, Nat Cell Biol, 10.1038/s41556-025-01795-7) = 3,422 apt-scout targets (broad detected proteome). The EV-Map CONSERVED EV proteome is 182 proteins (42 non-EV); apt-scout matches 104 of these conserved EV-hallmark proteins as targets by gene (the other 78 are not apt-scout targets). Use the ev_hallmark_targets query for that subset. IMPORTANT: EV-Map detection means the protein is EV CARGO (present in the vesicle) — it does NOT mean surface-exposed. Rai & Greening 2025 run a separate membrane-impermeant biotinylation assay giving a 151-protein SURFACEOME, and show the conserved SDCBP/syntenin is luminal (not surface-accessible). For genuine EV-surface accessibility use that 151-protein set, not EV-Map presence.
has_known_aptamer
1 if PubMed '(gene) AND (aptamer OR SELEX)' returned any hit (KEYWORD co-mention, includes false positives — NOT a verified aptamer). For verified aptamers with Kd, see the Binding-affinities (v_kd) layer.
opentargets_top_disease_score
Open Targets association score (0-1).
aptamer_count_pubmed
Number of PubMed hits for (this protein) AND (aptamer OR SELEX). Keyword co-occurrence — verify each (many co-mention without a real aptamer).
aptamer_pmids
The actual PubMed IDs behind the aptamer evidence — click each to read the paper. This is the source of the 'has aptamer' claim.
surface_class
PREDICTED membrane topology (HPA-derived, not a measurement): A_surface = integral/ecto cell-surface (predicted EV-surface accessible); A2_pm_peripheral = plasma-membrane cytoplasmic-leaflet (SRC/LYN/RHOA, predicted not reachable); A_assoc = secreted/corona; B_cargo = luminal cargo; unknown = no HPA localization. Lipid asymmetry can partially flip (PS via scramblase); confirm by protease-protection / intact-EV surface labelling. See v_surface_targets.

455 rows where has_cryoEM = 0, surface_class = "A_surface" and tier = "Tier 1.5" sorted by evidence_priority descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: pdb_count_total, aptamer_count_pubmed

in_cev_map 2

  • 0 305
  • 1 150

has_structure 2

  • 0 329
  • 1 126

has_known_aptamer 2

  • 0 385
  • 1 70

has_activation_state_pdb_pair 2

  • 0 454
  • 1 1

tier 1

  • Tier 1.5 · 455 ✖

surface_class 1

  • A_surface · 455 ✖

has_cryoEM 1

  • - · 455 ✖
id gene_symbol protein_name tier evidence_priority ▲ has_structure surface_class pdb_count_total alphafold_mean_pLDDT has_cryoEM has_activation_state_pdb_pair activation_state_pdb_active activation_state_pdb_inactive has_known_aptamer aptamer_count_pubmed aptamer_pmids in_cev_map opentargets_top_disease_name opentargets_top_disease_score
P00813 ADA Adenosine deaminase Tier 1.5 0.957 1 A_surface 2 96.56 0 0     1 72 42012076, 41877526, 41762796, 41635914, 40403280, 40189053, 39856849, 39847085, 36796307, 33998617, 32043202, 30876536, 30060448, 27589406, 26606306, 25597304, 25521724, 25360869, 24976151, 24893272, 24682016, 24035856, 23462984, 23202335, 23037591, 22944024, 22613226, 41910181, 41791686, 41267360, 39673485, 39396299, 38583236, 36855421, 34241023, 33147453, 32546280, 30926472, 26605646, 24624989, 23373863, 22543727, 20345118, 19381549, 19378312, 18293985, 17440909, 17000903, 16856187, 16619330 1 Severe combined immunodeficiency due to adenosine deaminase deficiency 0.8556816060494579
P51795 CLCN5 H(+)/Cl(-) exchange transporter 5 Tier 1.5 0.955 1 A_surface 2 80.62 0 0     0 0   1 Dent disease type 1 0.850724240157394
P25189 MPZ Myelin protein P0 Tier 1.5 0.951 1 A_surface 2 81.69 0 0     0 0   1 Charcot-Marie-Tooth disease type 1B 0.8377022197539885
P36888 FLT3 Receptor-type tyrosine-protein kinase FLT3 Tier 1.5 0.949 1 A_surface 11 75.94 0 0     1 6 41733039, 34364920, 31434881, 30237882, 29299123, 22411871 1 acute myeloid leukemia 0.8313389209288576
P13473 LAMP2 Lysosome-associated membrane glycoprotein 2 Tier 1.5 0.948 1 A_surface 2 83.19 0 0     0 0   1 Glycogen Storage Disease Type 2b 0.8273010649608126
P04626 ERBB2 Receptor tyrosine-protein kinase erbB-2 Tier 1.5 0.934 1 A_surface 63 74.0 0 0     1 119 41836728, 41744190, 41540559, 41494763, 41413339, 41321156, 41297941, 40851486, 40761795, 40494827, 40403699, 40382399, 40223744, 40220375, 40120226, 40080161, 40056884, 39873777, 39809083, 39756158, 39748051, 39643321, 39609809, 39539244, 39263860, 39233482, 39177424, 38901393, 38813974, 38789508, 38693181, 38679242, 38604040, 38409854, 38066021, 37729138, 37659641, 37591183, 37522239, 37392577, 37038354, 36272296, 36255496, 36001395, 35504229, 34952586, 34476602, 34236165, 33876310, 33627408 1 non-small cell lung carcinoma 0.7789523142843545
O94856 NFASC Neurofascin Tier 1.5 0.933 1 A_surface 2 76.31 0 0     0 0   1 neurodevelopmental disorder with central and peripheral motor dysfunction 0.7782432580663833
Q15746 MYLK Myosin light chain kinase, smooth muscle Tier 1.5 0.93 1 A_surface 7 65.88 0 0     0 0   1 aortic aneurysm, familial thoracic 7 0.7659842793171938
P24394 IL4R Interleukin-4 receptor subunit alpha Tier 1.5 0.923 1 A_surface 10 54.75 0 0     1 3 32751068, 27819142, 22282665 1 asthma 0.742115080702623
P16671 CD36 Platelet glycoprotein 4 Tier 1.5 0.921 1 A_surface 1 93.94 0 0     1 6 41713143, 41140242, 39762152, 33596054, 33291667, 31904170 1 platelet-type bleeding disorder 10 0.7360571429413174
Q02413 DSG1 Desmoglein-1 Tier 1.5 0.92 1 A_surface 1 62.06 0 0     0 0   1 severe dermatitis-multiple allergies-metabolic wasting syndrome 0.7335328506238418
P09758 TACSTD2 Tumor-associated calcium signal transducer 2 Tier 1.5 0.919 1 A_surface 7 82.69 0 0     1 4 41384307, 41241473, 40050871, 39250993 1 gelatinous drop-like corneal dystrophy 0.7293087728162646
P08637 FCGR3A Low affinity immunoglobulin gamma Fc region receptor III-A Tier 1.5 0.912 1 A_surface 15 85.69 0 0     1 2 41249026, 21531729 1 autosomal recessive primary immunodeficiency with defective spontaneous natural killer cell cytotoxicity 0.7061437347032623
Q13555 CAMK2G Calcium/calmodulin-dependent protein kinase type II subunit gamma Tier 1.5 0.891 1 A_surface 2 78.38 0 0     0 0   1 intellectual developmental disorder 59 0.6354497016986491
Q92956 TNFRSF14 Tumor necrosis factor receptor superfamily member 14 Tier 1.5 0.879 1 A_surface 8 79.94 0 0     0 0   1 diffuse large B-cell lymphoma 0.5983171413833771
P01597 IGKV1-39 Immunoglobulin kappa variable 1-39 Tier 1.5 0.876 1 A_surface 2 90.5 0 0     0 0   1 cutaneous Leishmaniasis 0.5868213846274001
P01764 IGHV3-23 Immunoglobulin heavy variable 3-23 Tier 1.5 0.876 1 A_surface 6 91.0 0 0     0 0   1 cutaneous Leishmaniasis 0.5868213846274001
P23083 IGHV1-2 Immunoglobulin heavy variable 1-2 Tier 1.5 0.876 1 A_surface 1 91.75 0 0     0 0   1 cutaneous Leishmaniasis 0.5868213846274001
P01593 IGKV1D-33 Immunoglobulin kappa variable 1D-33 Tier 1.5 0.876 1 A_surface 6 90.88 0 0     0 0   1 cutaneous Leishmaniasis 0.5868213846274001
P06312 IGKV4-1 Immunoglobulin kappa variable 4-1 Tier 1.5 0.876 1 A_surface 10 90.62 0 0     0 0   1 cutaneous Leishmaniasis 0.5868213846274001
Q96D96 HVCN1 Voltage-gated hydrogen channel 1 Tier 1.5 0.865 1 A_surface 2 69.75 0 0     0 0   1 Joubert syndrome 0.5504227269701596
Q9P1W8 SIRPG Signal-regulatory protein gamma Tier 1.5 0.864 1 A_surface 2 85.5 0 0     0 0   1 type 1 diabetes mellitus 0.5457344827318543
O15155 BET1 BET1 homolog Tier 1.5 0.864 1 A_surface 1 83.06 0 0     0 0   1 neurodegenerative disease 0.5468418315282804
P34741 SDC2 Syndecan-2 Tier 1.5 0.863 1 A_surface 1 60.84 0 0     0 0   1 COVID-19 0.5422254875204983
P15260 IFNGR1 Interferon gamma receptor 1 Tier 1.5 0.862 1 A_surface 5 66.0 0 0     1 2 33667716 1 disseminated atypical mycobacterial infection 0.5414012388034828
O00161 SNAP23 Synaptosomal-associated protein 23 Tier 1.5 0.859 1 A_surface 2 82.12 0 0     0 0   1 neurodegenerative disease 0.5288361677964304
P21926 CD9 CD9 antigen Tier 1.5 0.858 1 A_surface 5 88.56 0 0     1 17 41999228, 41625383, 40618375, 39266887, 38866706, 38057814, 37585601, 37351166, 37019008, 36704890, 34647460, 34505435, 33304477, 32730952, 32207293, 28959386 1 diphtheria 0.5261379875719714
P54756 EPHA5 Ephrin type-A receptor 5 Tier 1.5 0.858 1 A_surface 2 79.38 0 0     0 0   1 neurodegenerative disease 0.5261379875719714
Q9HCM2 PLXNA4 Plexin-A4 Tier 1.5 0.856 1 A_surface 1 83.06 0 0     0 0   1 neurodegenerative disease 0.518371001420808
P13591 NCAM1 Neural cell adhesion molecule 1 Tier 1.5 0.852 1 A_surface 7 79.5 0 0     1 1 36649818 1 smoking initiation 0.5071020926446286
P15814 IGLL1 Immunoglobulin lambda-like polypeptide 1 Tier 1.5 0.85 1 A_surface 3 75.06 0 0     0 0   1 isolated agammaglobulinemia 0.4996673834185043
P18084 ITGB5 Integrin beta-5 Tier 1.5 0.846 1 A_surface 3 82.19 0 0     0 0   1 migraine disorder 0.48652455084344876
A1L3X0 ELOVL7 Very long chain fatty acid elongase 7 Tier 1.5 0.828 1 A_surface 1 89.75 0 0     0 0   1 substance-related disorder 0.4271436896798171
Q92854 SEMA4D Semaphorin-4D Tier 1.5 0.828 1 A_surface 2 80.81 0 0     0 0   1 skin aging 0.4259843235238637
P20702 ITGAX Integrin alpha-X Tier 1.5 0.825 1 A_surface 9 88.0 0 0     0 0   1 neurodegenerative disease 0.41708750879240836
Q9P121 NTM Neurotrimin Tier 1.5 0.824 1 A_surface 2 82.38 0 0     1 2 35699468, 26194558 1 smoking initiation 0.41382172436739945
Q14242 SELPLG P-selectin glycoprotein ligand 1 Tier 1.5 0.82 1 A_surface 1 50.38 0 0     1 1 25979951 1 glaucoma 0.40058604767334977
P08571 CD14 Monocyte differentiation antigen CD14 Tier 1.5 0.818 1 A_surface 1 84.75 0 0     1 14 41636061, 41542672, 41140242, 38477735, 38280803, 37162508, 36716100, 36475636, 32589412, 32515246, 30900705, 30563044, 25483705, 12498773 1 dengue disease 0.39219972762611355
P35080 PFN2 Profilin-2 Tier 1.5 0.817 1 A_surface 1 95.5 0 0     0 0   1 smoking initiation 0.38873499449725424
Q08554 DSC1 Desmocollin-1 Tier 1.5 0.81 1 A_surface 2 76.75 0 0     0 0   1 atopic eczema 0.3674657640592667
O95255 ABCC6 ATP-binding cassette sub-family C member 6 Tier 1.5 0.809 1 A_surface 4 80.94 0 0     0 0   0 Pseudoxanthoma elasticum 0.864631668818611
O75144 ICOSLG ICOS ligand Tier 1.5 0.803 1 A_surface 2 82.56 0 0     0 0   1 immunodeficiency 119 0.34184658238916177
P30968 GNRHR Gonadotropin-releasing hormone receptor Tier 1.5 0.799 1 A_surface 1 84.19 0 0     0 0   0 hypogonadotropic hypogonadism 0.83100005285263
P10912 GHR Growth hormone receptor Tier 1.5 0.799 1 A_surface 9 58.69 0 0     1 5 38811951, 38477735, 31603904 0 Laron syndrome 0.8304020079647765
Q13308 PTK7 Inactive tyrosine-protein kinase 7 Tier 1.5 0.796 1 A_surface 1 82.69 0 0     1 110 41949051, 41786503, 41782379, 41780252, 41473803, 41172349, 41097888, 41065179, 41047832, 40987771, 40652441, 40618375, 40556592, 40488675, 40479736, 40415219, 40388621, 40274545, 40033943, 39933564, 39583320, 39468753, 39405917, 39315658, 39226482, 39211579, 39161311, 39127174, 38985770, 38922365, 38889444, 38773263, 38708542, 38695582, 38642044, 38466380, 38359901, 38148412, 38064592, 37974961, 37480788, 37473438, 37458448, 37247456, 37105082, 37003060, 36765879, 36722904, 36722696, 36471380 1 neurodegenerative disease 0.3194172724024113
O75015 FCGR3B Low affinity immunoglobulin gamma Fc region receptor III-B Tier 1.5 0.795 1 A_surface 6 88.62 0 0     0 0   1 Takayasu arteritis 0.3170299762085396
O43525 KCNQ3 Potassium voltage-gated channel subfamily KQT member 3 Tier 1.5 0.789 1 A_surface 1 56.72 0 0     0 0   0 Benign familial neonatal seizures 0.7961763561533409
P37023 ACVRL1 Activin receptor type-1-like Tier 1.5 0.789 1 A_surface 7 82.0 0 0     0 0   0 telangiectasia, hereditary hemorrhagic, type 2 0.7951167515831324
P16410 CTLA4 Cytotoxic T-lymphocyte protein 4 Tier 1.5 0.787 1 A_surface 22 80.12 0 0     1 26 41907643, 40972397, 40870970, 40811947, 40536609, 39417693, 38473398, 38158454, 36966395, 36831533, 36603108, 36015348, 33970170, 32929022, 32840510, 32280743, 32024070, 31405808, 28918052, 28082399, 26030229, 25565435, 24892807, 23460536, 23460531, 14612549 0 autoimmune lymphoproliferative syndrome due to CTLA4 haploinsufficiency 0.7906408646569979
Q13698 CACNA1S Voltage-dependent L-type calcium channel subunit alpha-1S Tier 1.5 0.786 1 A_surface 2 71.81 0 0     0 0   0 hypokalemic periodic paralysis, type 1 0.7869997029542154

Next page

Advanced export

JSON shape: default, array, newline-delimited

CSV options:

CREATE VIEW v_targets AS
SELECT f.id, n.gene_symbol, n.protein_name, tg.tier,
 -- evidence_priority: DETERMINISTIC, reproducible from real DB columns (no LLM).
 -- Transparent weights over harvested evidence: structure 0.35, disease importance
 -- 0.30 (Open Targets top-disease score), PREDICTED surface accessibility 0.20,
 -- EV detection 0.15. A heuristic ranking aid, not a validation; surface/EV terms
 -- are predictions/detections, NOT measured EV-surface exposure.
 ROUND(
   0.35*(CASE WHEN CAST(COALESCE(f.pdb_count_total,'0') AS INTEGER)>0 THEN 1.0
              WHEN CAST(COALESCE(NULLIF(f.alphafold_mean_pLDDT,''),'0') AS REAL)>0 THEN 0.3 ELSE 0.0 END)
 + 0.30*MIN(CAST(COALESCE(NULLIF(f.opentargets_top_disease_score,''),'0') AS REAL), 1.0)
 + 0.20*(CASE sc.surface_class WHEN 'A_surface' THEN 1.0 WHEN 'A_assoc' THEN 0.5 WHEN 'A2_pm_peripheral' THEN 0.2 ELSE 0.0 END)
 + 0.15*(CASE WHEN CAST(COALESCE(f.in_cev_map,0) AS INTEGER)=1 THEN 1.0 ELSE 0.0 END)
 , 3) AS evidence_priority,
 (CASE WHEN CAST(COALESCE(f.pdb_count_total,'0') AS INTEGER)>0 THEN 1 ELSE 0 END) AS has_structure,
 sc.surface_class,
 f.pdb_count_total, f.alphafold_mean_pLDDT, f.has_cryoEM,
 f.has_activation_state_pdb_pair, f.activation_state_pdb_active, f.activation_state_pdb_inactive,
 f.has_known_aptamer, f.aptamer_count_pubmed, ap.aptamer_pmids,
 f.in_cev_map, f.opentargets_top_disease_name, f.opentargets_top_disease_score
FROM v_target_full f
LEFT JOIN target_names n ON n.target_id=f.id
LEFT JOIN targets tg ON tg.id=f.id
LEFT JOIN target_aptamer_pmids ap ON ap.target_id=f.id
LEFT JOIN membrane_surface_class sc ON sc.target_id=f.id;
Powered by Datasette · Queries took 2007.234ms · Data license: CC BY 4.0 · Data source: apt-scout automated curation pipeline (E. Dohi, NCNP) — values harvested from public databases; raw source stored per target